| abstract |
The present invention relates to a combination of a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof which are used as an IAP inhibitor, and an immune checkpoint inhibitor; and use of the combination in the preparation of a cancer treatment drug. <img file="dest_path_image001.jpg" he="46.57" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="68.53"/> |